Privacy Policy
Signals Blog

Contributors

Categories

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Posts by: Stacey


Right Turn: A look at CIRM, Catapult and CCRM

Author: Stacey Johnson, 06/25/21

Back in November 2020, California voters approved Proposition 14. That means US$5.5B is being directed to the California Institute for Regenerative Medicine (CIRM) to support promising cell and gene therapy research so the organization can continue the important work it began in 2004. Although CIRM had quite a head start and launched with very impressive […]

Right Turn: CCRM celebrates 10 years (and the executives get their groove on!)

Author: Stacey Johnson, 06/11/21

“There’s a party going on right here, a celebration to last throughout the years, so bring your good times and your laughter too, we gonna celebrate your party with you.” – Kool & The Gang, Eumir Deodato June 14, 2021, is the 10-year anniversary of CCRM’s launch. For those of us who have been around […]

Right Turn: Cormac McCarthy and me on how to write a good science paper

Author: Stacey Johnson, 05/28/21

Cormac McCarthy is a Pulitzer prize-winning author. I am not. What we do have in common is that neither of us is a scientist. But we share a desire to impart good writing tips on the world. Cormac McCarthy’s platform is huge while I’m just happy if I can help anyone become a better writer. […]

Right Turn: Careers in advanced manufacturing

Author: Stacey Johnson, 05/07/21

The incredible, non-stop growth of the global cell and gene therapy market – valued at ~$12 billion by 2025 – means that talent is in high demand. (That estimate does not include tissue engineering, but it still seems low.) While seasoned professionals and those with leadership and hybrid skills are harder to come by, the […]

Right Turn: How stem cells may help people with epilepsy

Author: Stacey Johnson, 03/26/21

Is it normal to have a pet disease? Ever since I did a project on epilepsy in grade 4, I’ve had an interest in this disorder that affects one percent of the Canadian population, and worldwide there are anywhere from 50-65 million people living with epilepsy, depending on the source. (Every year, 15,500 Canadians learn […]